

McArthur Laboratory
27 posts

@McArthurLab
Improving melanoma patient outcomes by understanding melanoma biology and therapy resistance. @PeterMacCC





Daring to hope for a pancreatic cancer advance, @MichaelKuanChi1 will today be announced as recipient of the Paul Dear Postdoctoral Fellowship - at the #aflhawkscats "Dare to Hope" match. Legacy of the late Hawthorn great Paul Dear. More: petermac.org/about-us/news-…





Super excited and grateful to receive an @NHMRC Ideas Grant to investigate mRNA transcript diversity in therapy induced plasticity in melanoma. Big gratitude to @McArthurGrant, @McArthurLab, @PeterMacRes & collaborators @ClarksysCorner and @AliciaOshlack tinyurl.com/ypahuf67

Thrilled to share that @tourdecure_aus released the outcomes of their 2023 Grant Round and Peter Mac achieved a remarkable 100 percent success rate on full applications, with 10 projects funded worth more than $800K. Read more: petermac.org/about-us/news-…

#MayIsMelanomaAwarenessMonth. Dr Aparna Rao, a postdoc with @McArthurLab, investigates the metabolism of melanoma cells. Her research may better predict patient relapse and help us to understand what causes resistance to immunotherapy and other targeted therapies.















The United States @DeptofDefense has called on Peter Mac to help in its fight against #melanoma, granting a million dollars to researcher Dr @Smith_Lorey. Read the full story: petermac.org/about-us/news-…




Congratulations to three of @PeterMacCC's most promising clinical researchers Dr Aparna Rao, Dr Julia Dubowitz and Dr Lewis Au, who have received 2023 Discovery Partner Fellowships! Read more: petermac.org/about-us/news-…

Is resistance to targeted therapy in cancer inevitable? Check out our perspective on a landmark study from @lab_marine that elegantly shows genetic vs non-genetic resistance in melanoma are predictable events. #relatedArticles" target="_blank" rel="nofollow noopener">cell.com/cancer-cell/fu…


